Skip to navigation bar Skip to breadcrumbs Skip to page content
clear place holder
Envelope icon E-mail Updates Teal square Text size:  a A A

Prevention of Human Immunodeficiency Virus (HIV) Infection: Preexposure Prophylaxis

Release Date: June 2019

Recommendation Summary

PopulationRecommendationGrade
(What's This?)
Persons at high risk of HIV acquisition

The USPSTF recommends that clinicians offer preexposure prophylaxis (PrEP) with effective antiretroviral therapy to persons who are at high risk of HIV acquisition.

A

To read the recommendation statement in JAMA, select here.

To read the evidence summary in JAMA, select here.

See the Clinical Considerations section for information about identification of persons at high risk and selection of effective antiretroviral therapy.

Clinical Summary

Clinical summaries are one-page documents that provide guidance to primary care clinicians for using recommendations in practice.

This summary is intended for use by primary care clinicians.

 
Current as of: June 2019

Internet Citation: Final Update Summary: Prevention of Human Immunodeficiency Virus (HIV) Infection: Preexposure Prophylaxis. U.S. Preventive Services Task Force. June 2019.
https://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/prevention-of-human-immunodeficiency-virus-hiv-infection-pre-exposure-prophylaxis

USPSTF Program Office   5600 Fishers Lane, Mail Stop 06E53A, Rockville, MD 20857